Literature DB >> 6791858

Mechanism of the resistance to cytotoxicity which precedes aflatoxin B1 hepatocarcinogenesis.

G E Neal, S A Metcalfe, R F Legg, D H Judah, J A Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6791858     DOI： 10.1093/carcin/2.5.457

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


× No keyword cloud information.
  10 in total

1.  Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1.

Authors:  E J Moss; D J Judah; M Przybylski; G E Neal
Journal:  Biochem J       Date:  1983-01-15       Impact factor: 3.857

2.  Effects of pre-treatment with aflatoxin on a second aflatoxin treatment in guinea pigs.

Authors:  W M Peden; J L Richard; J R Thurston; J L Sacks
Journal:  Mycopathologia       Date:  1987-08       Impact factor: 2.574

Review 3.  Defective drug uptake contributing to multidrug resistance in hepatoma cells can be evaluated in vitro.

Authors:  H P Buscher
Journal:  Klin Wochenschr       Date:  1990-05-04

4.  Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.

Authors:  L I McLellan; D J Judah; G E Neal; J D Hayes
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

5.  Preferential over-expression of the class alpha rat Ya2 glutathione S-transferase subunit in livers bearing aflatoxin-induced pre-neoplastic nodules. Comparison of the primary structures of Ya1 and Ya2 with cloned class alpha glutathione S-transferase cDNA sequences.

Authors:  J D Hayes; L A Kerr; D J Harrison; A D Cronshaw; A G Ross; G E Neal
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

6.  Effects of neem leaf extract on production of aflatoxins and activities of fatty acid synthetase, isocitrate dehydrogenase and glutathione S-transferase in Aspergillus parasiticus.

Authors:  A Allameh; M Razzaghi Abyane; M Shams; M B Rezaee; K Jaimand
Journal:  Mycopathologia       Date:  2002       Impact factor: 2.574

7.  Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.

Authors:  Natalie M Johnson; Patricia A Egner; Victoria K Baxter; Michael B Sporn; Ryan S Wible; Thomas R Sutter; John D Groopman; Thomas W Kensler; Bill D Roebuck
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-24

8.  A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant.

Authors:  D J Judah; J D Hayes; J C Yang; L Y Lian; G C Roberts; P B Farmer; J H Lamb; G E Neal
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

Review 9.  Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.

Authors:  C P Wild; L A Jansen; L Cova; R Montesano
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

10.  Selection pressure and altered hepatocellular islands after a single injection of aflatoxin B1.

Authors:  M A Moore; K Nakagawa; T Ishikawa
Journal:  Jpn J Cancer Res       Date:  1988-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.